ANAB vs CPRT · rev $234.6M vs P/E 19, rev $3.51B
AnaptysBio Inc (ANAB) versus Copart Inc (CPRT) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Copart Inc (CPRT) is a specialty business services company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
ANAB currently screens at market cap $1.62B. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Not investment advice. Open the ANAB and CPRT stock pages for the full models.
Not investment advice.